Mitchell P. Kopin 13D/13G Filings for AIkido Pharma Inc. (AIKI)

Mitchell P. Kopin 13D and 13G filings for AIkido Pharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-06-14
06:01 am
Purchase
2022-06-07 13G AIkido Pharma Inc.
AIKI
Mitchell P. Kopin 223,082
4.200%
190,746increase
(+589.89%)
Filing